Urokinase for Injection Manufacturers PAN India, Suppliers
Leading Manufacturer of Urokinase for Injection 250000IU (UVANTAJ)
Taj Pharma India stands as the top-tier manufacturer, exporter, and supplier of Urokinase for Injection 250000IU (UVANTAJ) from Vapi, Gujarat, India. Our commitment to excellence, efficacy, and global compliance makes us the preferred choice for healthcare institutions across India, Africa, the Middle East, and LATAM regions. Known for producing pharmaceuticals with stringent quality assurance standards, Taj Pharmaceuticals Ltd ensures that every vial of Urokinase meets international benchmarks of purity, potency, and safety.
What is Urokinase for Injection 250000IU?
Urokinase for Injection is a life-saving thrombolytic agent used to dissolve dangerous blood clots in the bloodstream. It plays a vital role in the management of acute myocardial infarction (heart attacks), pulmonary embolism, stroke, and deep vein thrombosis. Administered under strict medical supervision, Urokinase restores blood flow to vital organs, thereby preventing irreversible tissue damage and improving patient outcomes.
Why Taj Pharma is the Best Manufacturer of Urokinase Injection 250000IU in India
At Taj Pharma India, we prioritize quality, consistency, and clinical effectiveness. Here’s why we’re a globally trusted name:
1. WHO-GMP & ISO Certified Manufacturing Facilities
We operate from state-of-the-art production plants in Vapi, Gujarat, that are WHO-GMP, EU-GMP, and ISO 9001:2015 certified. Our advanced infrastructure ensures contamination-free environments, adhering to international standards for parenteral preparations.
2. Unmatched Product Purity and Stability
Urokinase for Injection 250000IU manufactured by Taj Pharma undergoes rigorous in-process testing to verify identity, sterility, potency, and absence of pyrogens. Our quality control team ensures batch-to-batch consistency, maximizing therapeutic outcomes.
3. PAN India and Global Distribution Network
Taj Pharma proudly serves hospitals, government tenders, and PCD pharma franchises across India, Africa, the Middle East, LATAM, and CIS countries. Our product is always in ready stock, ensuring uninterrupted supply chains even for emergency needs.
4. Expert Regulatory Support
With decades of regulatory experience, we provide complete dossiers, including CTD formats, COAs, stability data, and manufacturing licenses. We are approved suppliers for institutional buyers, government procurement bodies, and private hospitals worldwide.
Therapeutic Indications of Urokinase Injection 250000IU
Urokinase is approved for a variety of critical cardiovascular and thrombotic disorders. Its major therapeutic uses include:
- Acute Myocardial Infarction (Heart Attack)
- Massive Pulmonary Embolism (PE)
- Peripheral Arterial Thrombosis
- Occluded Catheters or Shunts
- Ischemic Stroke (Under Strict Clinical Guidelines)
- Deep Vein Thrombosis (DVT)
Mechanism of Action: How Urokinase Works
Urokinase is a plasminogen activator that converts plasminogen into plasmin. This plasmin enzyme degrades fibrin clots, effectively dissolving thrombi in blood vessels. The drug facilitates the restoration of blood flow, thus preserving tissues and preventing permanent organ damage.
Dosage and Administration
Urokinase is administered intravenously, typically under ICU conditions. The dose and duration are determined by the severity of the condition and the patient’s response. A typical adult dose ranges between 250,000 IU to 1,000,000 IU, infused over several hours. Only trained medical professionals should administer this medication.
Clinical Safety and Precautions
Pregnancy and Breastfeeding
- Considered relatively safe in pregnancy; animal studies show minimal fetal risk.
- Probably safe during breastfeeding as per limited human data.
Renal and Hepatic Impairment
- Urokinase appears safe in patients with kidney disease, but close monitoring is essential.
- Caution is advised in hepatic patients, as liver function affects drug metabolism.
Alcohol Interaction
- No significant interaction reported. However, always consult your physician.
Side Effects of Urokinase Injection
While generally well-tolerated, Urokinase may cause side effects, such as:
- Bleeding or hemorrhage (most common)
- Hypotension
- Fever or chills
- Allergic reactions
- Nausea
Patients must be monitored continuously for signs of internal or external bleeding, and supportive care should be readily available.
Packaging & Storage
- Strength: 250000 IU per vial
- Dosage Form: Lyophilized powder for reconstitution
- Route of Administration: Intravenous
- Packaging: Sterile glass vials in carton with leaflet
- Storage: Store below 25°C. Protect from light and moisture.
Taj Pharma: Global Reach and Export Leadership
Taj Pharma India is a leading exporter of Urokinase Injection across more than 48 countries, including:
- Africa (Nigeria, Ghana, Kenya, South Africa)
- Middle East (UAE, Saudi Arabia, Iraq)
- LATAM (Peru, Ecuador, Brazil)
- CIS Countries (Russia, Ukraine, Kazakhstan)
Our export services include private labeling, contract manufacturing, and regulatory support for tender-based supplies.
Urokinase PCD Franchise Opportunities
Taj Pharma invites entrepreneurs, distributors, and pharma professionals to join us as PCD pharma franchise partners for Urokinase Injection. We offer:
- Monopoly-based distribution rights
- Competitive pricing
- Marketing support & visual aids
- Promotional materials and samples
- Assured delivery timelines
Why Choose Taj Pharmaceuticals for Urokinase?
✅ WHO-GMP & EU-GMP Approved
✅ 250+ Global Product Registrations
✅ Fast & Assured Exports
✅ Transparent Pricing Policy
✅ Regulatory-Compliant Product Dossiers
✅ 100% Quality Assurance with COA & Stability Reports
✅ Available for Hospital Supply, Distributors & PCD Franchises
Urokinase Injection 250000IU – Taj Pharma Product Details
| Product Name | Urokinase for Injection 250000IU (UVANTAJ) |
|---|---|
| Brand Name | UVANTAJ |
| Dosage Form | Lyophilized Powder for Injection |
| Strength | 250000 IU |
| Route of Administration | Intravenous (IV) |
| Packing | 1 vial per carton with leaflet |
| Manufacturer | Taj Pharmaceuticals Ltd., Vapi, India |
| Therapeutic Class | Thrombolytic Agent |
| Indication | Blood Clot Dissolution |
| Export Markets | India, Africa, Middle East, LATAM, CIS |
| Certifications | WHO-GMP, ISO, EU-GMP (on request) |
Contact Taj Pharma for Bulk Orders or Franchise Inquiries
📍 Address: Taj Pharmaceuticals Ltd., Vapi, Gujarat, India
📞 Call/WhatsApp: +91 84484 44095
📠 Fax: +91 – 22 – 2634 1274
📧 Email: info@tajpharma.com
🌐 Website: www.tajpharma.com
If you’re a distributor, hospital buyer, or pharma partner looking for a reliable supplier of Urokinase for Injection 250000IU, Taj Pharma is your trusted pharmaceutical ally for global-standard quality, compliance, and affordability.
